ConductScience.org, home

Paper32864635

Therapeutic Targeting of Follicular T Cells with Chimeric Antigen Receptor-Expressing Natural Killer Cells.

Reighard SD and 11 others. Cell Rep Med, 2020. Cited by 55 papers, by iCite.

Cite this record

ConductScience Library. Therapeutic Targeting of Follicular T Cells with Chimeric Antigen Receptor-Expressing Natural Killer Cells. Papers, record 32864635. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32864635

Download JSON
Cell line
HEK293T2,726 papers
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Therapeutic Targeting of Follicular T Cells with Chimeric Antigen Receptor-Expressing Natural Killer Cells.
PubMed
Journal
Cell Rep Med
PubMed
Year
2020
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
55
iCite
Relative citation ratio, by iCite
2.09
iCite
Revised in PubMed
2022-12-02
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Reighard SDSeth D
2Cranert SAStacey A
3Rangel KMKelly M
4Ali AAyad
5Gyurova IEIvayla E
6de la Cruz-Lynch ATArthur T
7Tuazon JAJasmine A
8Khodoun MVMarat V
9Kottyan LCLeah C
10Smith DFDavid F
11Brunner HIHermine I
12Waggoner SNStephen N

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Killer Cells, NaturalMajor topic
Receptors, Chimeric AntigenMajor topic
T-LymphocytesMajor topic
Adult
Animals
Autoimmune Diseases
Autoimmunity
Cells, Cultured
Child
Child, Preschool
Drosophila melanogaster
Female
Humans
Immunotherapy, Adoptive
Male
Mice
Mice, Inbred NOD
Mice, SCID
Mice, Transgenic

Source PubMed

Download CSV of topics

Grants8

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
DP1 DA038017NIDA NIH HHSUnited StatesDP1DA038017PubMed and NIHNIH RePORTER
R01 AR073228NIAMS NIH HHSUnited StatesR01AR073228PubMed and NIHNIH RePORTER
S10 OD023410NIH HHSUnited StatesS10OD023410PubMed and NIHNIH RePORTER
R01 AI148080NIAID NIH HHSUnited StatesR01AI148080PubMed and NIHNIH RePORTER
R01 DK107502NIDDK NIH HHSUnited StatesR01DK107502PubMedNIH RePORTER
T32 GM063483NIGMS NIH HHSUnited StatesT32GM063483PubMed and NIHNIH RePORTER
P30 AR070549NIAMS NIH HHSUnited StatesP30AR070549PubMed and NIHNIH RePORTER
T32 AI118697NIAID NIH HHSUnited StatesT32AI118697PubMed and NIHNIH RePORTER

Download CSV of grants

Comments and corrections2

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn PapersSource
Erratum in33205070Erratum: Therapeutic Targeting of Follicular T Cells with Chimeric Antigen Receptor-Expressing Natural Killer Cells.https://conductscience.org/library/papers/33205070PubMed
Comment in33205057CAR NK Cell Therapy for T Follicular Helper Cells.https://conductscience.org/library/papers/33205057PubMed

Download CSV of comments and corrections

References53

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
122549246Follicular helper T cells in immunity and systemic autoimmunity.Nat Rev Rheumatol2012https://conductscience.org/library/papers/22549246PubMed
229192160A Novel Human Systemic Lupus Erythematosus Model in Humanised Mice.Sci Rep2017https://conductscience.org/library/papers/29192160PubMed
327695002Suppression by TFR cells leads to durable and selective inhibition of B cell effector function.Nat Immunol2016https://conductscience.org/library/papers/27695002PubMed
427014270Natural Killer Cells for Immunotherapy - Advantages of the NK-92 Cell Line over Blood NK Cells.Front Immunol2016https://conductscience.org/library/papers/27014270PubMed
528150777Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis.Nature2017https://conductscience.org/library/papers/28150777PubMed
632023374Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors.N Engl J Med2020https://conductscience.org/library/papers/32023374PubMed
725581113Circulating follicular helper-like T cells in systemic lupus erythematosus: association with disease activity.Arthritis Rheumatol2015https://conductscience.org/library/papers/25581113PubMed
827501245Follicular CXCR5- expressing CD8(+) T cells curtail chronic viral infection.Nature2016https://conductscience.org/library/papers/27501245PubMed
924274181Chimeric antigen receptor therapy for cancer.Annu Rev Med2014https://conductscience.org/library/papers/24274181PubMed
1030034945First-in-man clinical trial of CAR NK-92 cells: safety test of CD33-CAR NK-92 cells in patients with relapsed and refractory acute myeloid leukemia.Am J Cancer Res2018https://conductscience.org/library/papers/30034945PubMed
1119221396Follicular helper T cells are required for systemic autoimmunity.J Exp Med2009https://conductscience.org/library/papers/19221396PubMed
1224815671Follicular helper T-cells: expanding roles in T-cell lymphoma and targets for treatment.Br J Haematol2014https://conductscience.org/library/papers/24815671PubMed
1327325434Follicular helper T cells mediate IgE antibody response to airborne allergens.J Allergy Clin Immunol2017https://conductscience.org/library/papers/27325434PubMed
1430396745PD-1 immunobiology in systemic lupus erythematosus.J Autoimmun2019https://conductscience.org/library/papers/30396745PubMed
1530666307Engineering and Design of Chimeric Antigen Receptors.Mol Ther Methods Clin Dev2019https://conductscience.org/library/papers/30666307PubMed
1619935804Dysregulation of germinal centres in autoimmune disease.Nat Rev Immunol2009https://conductscience.org/library/papers/19935804PubMed
1729605760Next generation natural killer cells for cancer immunotherapy: the promise of genetic engineering.Curr Opin Immunol2018https://conductscience.org/library/papers/29605760PubMed
1815585893
T cell activation by antibody-like immunoreceptors: increase in affinity of the single-chain fragment domain above threshold does not increase T cell activation against antigen-positive target cells but decreases selectivity.
J Immunol2004https://conductscience.org/library/papers/15585893PubMed
1920686503AML xenograft efficiency is significantly improved in NOD/SCID-IL2RG mice constitutively expressing human SCF, GM-CSF and IL-3.Leukemia2010https://conductscience.org/library/papers/20686503PubMed
2020033635Use of transfected Drosophila S2 cells to study NK cell activation.Methods Mol Biol2010https://conductscience.org/library/papers/20033635PubMed

See all 53 referencesDownload CSV of references

Cited by35

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 55 citations.

PMIDTitleJournalYearIn PapersSource
42552386High-resolution promoter interaction analysis implicates genes involved in activation of type 3 innate lymphoid cells in immune disease risk.Nat Genet2026https://conductscience.org/library/papers/42552386PubMed
42498736Targeting T follicular helper cells for lifelong health.Nat Rev Drug Discov2026https://conductscience.org/library/papers/42498736PubMed
42317359Chimeric antigen receptor technology: an emerging translational immunotherapy in nonneoplastic diseases.Front Immunol2026https://conductscience.org/library/papers/42317359PubMed
42030390Targeting PD-1+ T cells with chimeric antigen receptors to reduce the HIV reservoir.Sci Adv2026https://conductscience.org/library/papers/42030390PubMed
41573945High-resolution promoter interaction analysis implicates genes involved in the activation of Type 3 Innate Lymphoid Cells in autoimmune disease risk.bioRxiv2026https://conductscience.org/library/papers/41573945PubMed
41558532CAR-T cell therapy: A new dawn in the treatment of autoimmune disease.Cell Transplant2026https://conductscience.org/library/papers/41558532PubMed
41528734CD40L and IL-4 lymph node-associated signals protect B cells from rituximab-induced ADCC via KIR and NKG2A.Clin Exp Immunol2026https://conductscience.org/library/papers/41528734PubMed
41329315A new era in CAR-NK cell therapy: from technological innovations to clinical applications.World J Pediatr2026https://conductscience.org/library/papers/41329315PubMed
41316450Challenges and strategies in clinical applications of CAR-T therapy for autoimmune diseases.J Hematol Oncol2025https://conductscience.org/library/papers/41316450PubMed
41145295[Frontier advances in chimeric antigen receptor T cells and chimeric antigen receptor regulatory T cells therapies for autoimmune diseases].Zhonghua Xue Ye Xue Za Zhi2025https://conductscience.org/library/papers/41145295PubMed
40747591Research progress on chimeric antigen receptor-based immunotherapy against autoimmune diseases.Hum Vaccin Immunother2025https://conductscience.org/library/papers/40747591PubMed
40524185Immune cell aberrations in Systemic Lupus Erythematosus: navigating the targeted therapies toward precision management.Cell Mol Biol Lett2025https://conductscience.org/library/papers/40524185PubMed
40481370From myth to bedside: a scoping review of the applications of the chimeric antigen receptor in rheumatology.Clin Exp Med2025https://conductscience.org/library/papers/40481370PubMed
40205818Diverse potential of chimeric antigen receptor-engineered cell therapy: Beyond cancer.Clin Transl Med2025https://conductscience.org/library/papers/40205818PubMed
39931050Cellular therapies in rheumatic and musculoskeletal diseases.J Transl Autoimmun2025https://conductscience.org/library/papers/39931050PubMed
39734406The advent of chimeric antigen receptor T Cell therapy in recalibrating immune balance for rheumatic autoimmune disease treatment.Front Pharmacol2024https://conductscience.org/library/papers/39734406PubMed
39697333From promise to practice: CAR T and Treg cell therapies in autoimmunity and other immune-mediated diseases.Front Immunol2024https://conductscience.org/library/papers/39697333PubMed
39511139Comprehensive snapshots of natural killer cells functions, signaling, molecular mechanisms and clinical utilization.Signal Transduct Target Ther2024https://conductscience.org/library/papers/39511139PubMed
38920310Current cell therapies for systemic lupus erythematosus.Stem Cells Transl Med2024https://conductscience.org/library/papers/38920310PubMed
38656354A new vision of the efficacy of both CAR-NK and CAR-T cells in treating cancers and autoimmune diseases.Med Oncol2024https://conductscience.org/library/papers/38656354PubMed

See all 35 cited byDownload CSV of cited by

Genes39

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
BCL6604PubTator's text mininghttps://conductscience.org/library/genes/604NCBI Gene
CD14929PubTator's text mininghttps://conductscience.org/library/genes/929NCBI Gene
CD19930PubTator's text mininghttps://conductscience.org/library/genes/930NCBI Gene
CD1C911PubTator's text mininghttps://conductscience.org/library/genes/911NCBI Gene
CD247919PubTator's text mininghttps://conductscience.org/library/genes/919NCBI Gene
CD27939PubTator's text mininghttps://conductscience.org/library/genes/939NCBI Gene
CD27429126PubTator's text mininghttps://conductscience.org/library/genes/29126NCBI Gene
CD28940PubTator's text mininghttps://conductscience.org/library/genes/940NCBI Gene
CD38952PubTator's text mininghttps://conductscience.org/library/genes/952NCBI Gene
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CD68968PubTator's text mininghttps://conductscience.org/library/genes/968NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
CR21380PubTator's text mininghttps://conductscience.org/library/genes/1380NCBI Gene
CSF21437PubTator's text mininghttps://conductscience.org/library/genes/1437NCBI Gene
CXCR5643PubTator's text mininghttps://conductscience.org/library/genes/643NCBI Gene
FCGR3A2214PubTator's text mininghttps://conductscience.org/library/genes/2214NCBI Gene
FN12335PubTator's text mininghttps://conductscience.org/library/genes/2335NCBI Gene
FOXP350943PubTator's text mininghttps://conductscience.org/library/genes/50943NCBI Gene
ICOS29851PubTator's text mininghttps://conductscience.org/library/genes/29851NCBI Gene
IGHE3497PubTator's text mininghttps://conductscience.org/library/genes/3497NCBI Gene

See all 39 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32864635

GET https://conductscience.org/api/papers/v1/32864635/references?page=2